Additionally, peptide therapy may not be appropriate for individuals taking immunosuppressant medications or those dealing with active systemic infections, autoimmune disorders, or poorly controlled metabolic conditions
Its value in a clinical setting comes from what it is not: it does not disrupt appetite, hormones, insulin, or IGF-1
For each peptide under consideration, FDA staff told the panelists they recommended against giving compounders the green light due to a lack of clinical evidence demonstrating safety and efficacy
B12/MIC is likely to be most effective when used as part of a healthy lifestyle, including a balanced diet and regular exercise
Thus, in metabolically healthy individuals, the fertility impact appears minimal